Myr-Tat-PKCbetaII is a cell permeable protein kinase C beta II peptide inhibitor. Myr-Tat-PKCbetaII mitigates the generation of reactive oxygen species in rat ex-vivo and porcine in-vivo ischemia-reperfusion injury[1].
Molecular Weight:
3047.57
Formula:
C131H220N46O34S2
Target:
PKC,Reactive Oxygen Species (ROS)
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted